Hellstrom et al. reported that the quantitation of the HE4 protein levels in serum was more frequently positive than that of the CA125 levels in ovarian cancer; therefore, it could be used as a biomarker of ovarian cancer [5]. Here, WFDC2 is linked to ovarian carcinoma.